NCT06511726View on ClinicalTrials.gov

Induction Chemotherapy Plus Cadonilimab for Locally Advanced Cervical Cancer

PHASE2RecruitingINTERVENTIONAL
Enrollment

29

Participants

Timeline

Start Date

January 23, 2024

Primary Completion Date

October 30, 2025

Study Completion Date

October 30, 2027

Conditions
Cervical Cancer
Interventions
DRUG

Cadonilimab

Induction chemotherapy and immunotherapy: Cadonilimab + cisplatin + albumin-bound paclitaxel, for a total of 2 cycles (cisplatin 75 mg/m² + albumin-bound paclitaxel 260 mg/m² q3w, Cadonilimab 10 mg/kg q3w).

Trial Locations (1)

510000

RECRUITING

Sun Yat-sen Memorial hosipital, Guangzhou

All Listed Sponsors
lead

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

OTHER